Publicacions en què col·labora amb Agueda González Rodríguez (50)

2024

  1. Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury

    Redox Biology, Vol. 71

2023

  1. Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis

    Biomarker Research, Vol. 11, Núm. 1

2022

  1. Ptpn1 deletion protects oval cells against lipoapoptosis by favoring lipid droplet formation and dynamics

    Cell Death and Differentiation, Vol. 29, Núm. 12, pp. 2362-2380

2020

  1. Defective liver glycogen autophagy related to hyperinsulinemia in intrauterine growth-restricted newborn wistar rats

    Scientific Reports, Vol. 10, Núm. 1

  2. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

    Cell Death and Disease, Vol. 11, Núm. 9

2019

  1. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 7

2018

  1. Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis

    Molecular Metabolism, Vol. 7, pp. 132-146

  2. SIRT1 Controls Acetaminophen Hepatotoxicity by Modulating Inflammation and Oxidative Stress

    Antioxidants and Redox Signaling, Vol. 28, Núm. 13, pp. 1187-1208

2017

  1. A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

    Hepatology, Vol. 65, Núm. 3, pp. 950-968

2016

  1. Corrigendum to "IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes" [Biochim. Biophys. Acta 1853 (12) (2015) 3224-3234] doi 10.1016/j.bbamcr.2015.09.020

    Biochimica et Biophysica Acta - Molecular Cell Research

  2. Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis

    Hepatology, Vol. 63, Núm. 2, pp. 604-619

  3. Friedelane-type triterpenoids as selective anti-inflammatory agents by regulation of differential signaling pathways in LPS-stimulated macrophages

    Toxicology and Applied Pharmacology, Vol. 313, pp. 57-67

  4. Increased oxidative stress and apoptosis in the hypothalamus of diabetic male mice in the insulin receptor substrate-2 knockout model

    DMM Disease Models and Mechanisms, Vol. 9, Núm. 5, pp. 573-583

  5. New therapeutic targets for the treatment of insulin resistance based on the paracrine cross-talk between hepatocytes and Kupffer cells

    Anales de la Real Academia Nacional de Farmacia, Vol. 82, Núm. 2, pp. 200-209

2015

  1. Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance

    Diabetes, Vol. 64, Núm. 5, pp. 1522-1531

  2. IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1853, Núm. 12, pp. 3224-3234

  3. Opposite cross-talk by oleate and palmitate on insulin signaling in hepatocytes through macrophage activation

    Journal of Biological Chemistry, Vol. 290, Núm. 18, pp. 11663-11677

  4. RNA interference as a therapeutic strategy for the treatment of liver diseases

    Current Pharmaceutical Design, Vol. 21, Núm. 31, pp. 4574-4586

  5. Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner

    Molecular Nutrition and Food Research, Vol. 59, Núm. 8, pp. 1431-1442

  6. Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection

    Food and Chemical Toxicology, Vol. 80, pp. 298-309